Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal

Search
OPEN ACCESS

Articles

Page Path
HOME > Diabetes Metab J > Ahead-of print > Article
Original Article
Complications Risk of End-Stage Kidney Disease in Individuals with Diabetes Living Alone: A Large-Scale Population-Based Study
Kyunghun Sung1*orcid, Jae-Seung Yun2*orcid, Bongseong Kim3, Hun-Sung Kim1,4, Jae-Hyoung Cho1,4, Yong-Moon Mark Park5,6, Kyungdo Han3orcidcorresp_icon, Seung-Hwan Lee1,4orcidcorresp_icon

DOI: https://doi.org/10.4093/dmj.2024.0578
Published online: April 5, 2025
  • 462 Views
  • 28 Download

1Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea

2Division of Endocrinology and Metabolism, Department of Internal Medicine, St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea

3Department of Statistics and Actuarial Science, Soongsil University, Seoul, Korea

4Department of Medical Informatics, College of Medicine, The Catholic University of Korea, Seoul, Korea

5Department of Epidemiology, Fay W. Boozman College of Public Health, University of Arkansas for Medical Sciences, Little Rock, AR, USA

6Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA

corresp_icon Corresponding authors: Seung-Hwan Lee orcid Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul 06591, Korea E-mail: hwanx2@catholic.ac.kr
Kyungdo Han orcid Department of Statistics and Actuarial Science, Soongsil University, 369 Sangdo-ro, Dongjak-gu, Seoul 06978, Korea E-mail: hkd917@naver.com
*Kyunghun Sung and Jae-Seung Yun contributed equally to this study as first authors.
• Received: September 20, 2024   • Accepted: December 12, 2024

Copyright © 2025 Korean Diabetes Association

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • Background
    Previous research has linked solitary living to various adverse health outcomes, but its association with diabetic complications among individuals with type 2 diabetes mellitus (T2DM) remains underexplored. We examined the risk of endstage kidney disease (ESKD) in individuals with diabetes living alone (IDLA).
  • Methods
    This population-based cohort study used the National Health Information Database of Korea, which included 2,432,613 adults with T2DM. Household status was determined based on the number of registered family members. IDLA was defined as continuously living alone for 5 years or more. A multivariable Cox proportional hazards model was used to evaluate the association between living alone and the risk of developing ESKD.
  • Results
    During a median follow-up of 6.0 years, 26,691 participants developed ESKD, with a higher incidence observed in the IDLA group than in the non-IDLA group. After adjusting for confounding variables, the hazard ratio for ESKD in the IDLA group was 1.10 (95% confidence interval, 1.06 to 1.14). The risk of ESKD was particularly elevated in younger individuals, those without underlying chronic kidney disease, with longer durations of living alone, and with low household income. Adherence to favorable lifestyle behaviors (no smoking, no alcohol consumption, and engaging in regular exercise) was associated with a significantly lower risk of ESKD, with a more pronounced effect in the IDLA group.
  • Conclusion
    Living alone was associated with a higher risk of ESKD in individuals with T2DM. Tailored medical interventions and social support for IDLA are crucial for the prevention of diabetic complications.
• Individuals with diabetes living had a 10% higher risk of ESKD than those not.
• Adhering to healthy lifestyle habits was linked to a significantly lower ESKD risk.
In recent decades, the number of individuals living alone has risen globally, especially in developed countries, and thus emerged as a significant social issue. The proportion of single-person households has reached 29%, equaling 38 million households, in the United States [1]. Similarly, Korea has seen a rapid increase in the percentage of single-person households, from 15.5% in 2000 to 33.4% in 2021 [2]. This trend of living alone is linked to changes in lifestyle habits, inadequate nutritional support, decreased physical activity, and limited social interactions [3,4]. Several studies have suggested that living alone is associated with adverse health outcomes such as mortality, cardiovascular disease, and type 2 diabetes mellitus (T2DM) [5-8]. However, few studies have specifically examined the association between living alone and the development of diabetic complications.
T2DM is associated with the risk of various micro- and macrovascular complications and is one of the most common causes of end-stage kidney disease (ESKD) [9]. The development and progression of diabetic complications during the natural history of the disease are profoundly influenced by glucose control and lifestyle factors. Favorable lifestyle factors could significantly reduce premature mortality in people with diabetes [10]. Given the importance of lifestyle management in people with T2DM, individuals with diabetes living alone (IDLA) might face challenges in maintaining a balanced diet, performing regular physical activity, and accessing medical care [11]. Considering that the prevalence of diabetic vascular complications was higher among patients with more barriers to self-care, IDLA might be particularly vulnerable to ESKD [12].
ESKD is a significant health burden, causing impaired quality of life and premature mortality [13]. Despite the well-documented effects of lifestyle factors on the progression of chronic kidney disease (CKD) [14], research into the specific link between IDLA and the risk of developing ESKD is absent. Understanding this association is critical because it could inform targeted interventions intended to mitigate the risk of ESKD in this vulnerable population. Therefore, we investigated this association using a nationally representative, large-scale database of nearly 2.5 million people with T2DM.
Study population and data source
This study used the Korean National Health Information Database (NHID), a public database established by the National Health Insurance System (NHIS). The NHID contains information on healthcare utilization, healthcare service claims and reimbursements, health examinations, sociodemographic variables, diagnosis and treatment variables, and mortality data for the residents of South Korea. The NHIS covers approximately 97% of the Korean population, with the remaining 3% covered by Medical Aid. Policyholders and their dependents who are 20 years of age or older are recommended to undergo health check-ups every 1 or 2 years, depending on their employment status. Further details of the NHID are described elsewhere [15,16]. In our study, the initial cohort comprised 2,616,828 individuals with T2DM who underwent health examinations in 2015–2016. Exclusions were made for individuals younger than 20 years (n=323) and those with missing household information (n=64,258), with missing variables from health examinations (n=85,299), with a previous diagnosis of ESKD (n=12,759), or with a diagnosis of ESKD within a year after the study enrollment date (n=21,576). Ultimately, the study population contained 2,432,613 subjects (Supplementary Fig. 1). This study was approved by the Institutional Review Board of Seoul St. Mary’s Hospital, The Catholic University of Korea (No. KC23ZASI0241). Anonymized and deidentified information was used for the analyses, and thus the requirement for informed consent was waived.
Measurements and definitions
Single-person households were defined based on the number of family members registered in the NHIS. IDLA was defined as continuously living alone for 5 years or more during the index year and the previous years. Information on current smoking, alcohol drinking, and exercise were obtained via self-administered questionnaires. Smoking status was categorized as nonsmoker, ex-smoker, and current smoker. Alcohol consumption was classified into none, mild, and heavy based on a daily intake of 30 g of alcohol [17]. Regular physical activity was defined as >30 minutes of moderate-intensity exercise at least five times per week or >20 minutes of vigorous-intensity exercise at least three times per week [18]. A healthy lifestyle score ranging from 0 to 3 was calculated by assigning one point each for being a non/ex-smoker, having no alcohol consumption, and performing regular exercise [19]. Low household income level was defined as being in the lowest 25% based on the amount of insurance premiums paid or being a recipient of Medical Aid. The presence of T2DM was defined according to the following criteria: (1) at least one claim per year under International Classification of Diseases, 10th Revision–Clinical Modification (ICD-10) codes E11–14 and at least one claim per year for the prescription of antidiabetic medication, or (2) fasting glucose level ≥126 mg/dL [20]. Obesity was defined as a body mass index (BMI) ≥25 kg/m2, in accordance with the Korean Society for the Study of Obesity criteria [21]. Hypertension was defined as the presence of at least one claim per year under ICD-10 codes I10 or I11 and at least one claim per year for the prescription of an antihypertensive agent or as a systolic/diastolic blood pressure ≥140/90 mm Hg. The presence of dyslipidemia was defined according to the presence of at least one claim per year under ICD-10 code E78 and at least one claim per year for the prescription of a lipid-lowering agent or as total cholesterol (TC) ≥240 mg/dL. CKD was defined as an estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m2. eGFR was calculated using the abbreviated Modification of Diet in Renal Disease formula: 175×serum creatinine (mg/dL)–1.154×age (yr)–0.203×(0.742 if female) [22]. Blood samples for the measurement of serum glucose, TC, high-density lipoprotein-cholesterol, low-density lipoprotein-cholesterol, triglycerides, and serum creatinine were drawn after an overnight fast. Hospitals performing health examinations are certified by the NHIS, and laboratory investigations were performed in accordance with the guidelines of the Korean Association of Laboratory Quality Control.
Study outcome and follow-up
The primary end point was incident ESKD, which was defined as a combination of ICD-10 codes (N18–19, Z49, Z94.0, or Z99.2), the initiation of renal replacement therapy, and/or kidney transplantation during hospitalization. Patients with ESKD are designated as Medical Aid beneficiaries, and all medical care expenses for dialysis are reimbursed by the Korean Health Insurance Review and Assessment Service. Consequently, the diagnostic codes for ESKD patients are strictly managed, ensuring high accuracy. Codes for treatment or medical expense claims were R3280 for kidney transplantation, O7011–O7020 or V001 for hemodialysis, and O7071–O7075 or V003 for peritoneal dialysis. We excluded individuals without previous CKD who had a transplantation or dialysis code on the same date as an acute kidney injury code. Subjects on continuous kidney replacement therapy or acute peritoneal dialysis due to acute kidney injury were also excluded [23]. The study population was followed from baseline to the date of ESKD diagnosis or December 31, 2022.
Statistical analysis
Baseline characteristics are presented as mean±standard deviation, median (interquartile range [IQR]), or number (%). The incidence rates of the outcome were calculated by dividing the number of incident cases by the total follow-up period (1,000 person-years). The incidence probability of the primary outcome according to the number of household members was calculated using Kaplan-Meier curves, and a log-rank test was performed to analyze differences between groups. Hazard ratios (HRs) and 95% confidence interval (CI) values for ESKD by household status were analyzed using a multivariable Cox proportional hazard regression model. Model 1 was unadjusted; model 2 was adjusted for age and sex; model 3 was further adjusted for BMI, smoking, alcohol drinking, regular exercise, income status, hypertension, dyslipidemia, and eGFR; and model 4 was further adjusted for the duration of diabetes, insulin treatment, and oral antidiabetic medications. A sensitivity analysis of the relationship between the duration of living alone (first time registrants in the index year, those living alone for less than 5 years, and those living alone for 5 years or more) and the risk of ESKD was based on yearly sequential household number data. In addition, the association between the risk of ESKD and the maintenance of healthy lifestyle habits (not drinking, not smoking, and being physically active) was evaluated. Potential effect modifications by age group, sex, smoking, alcohol consumption, regular exercise, presence or absence of obesity, eGFR levels, insulin use, number of oral antidiabetic medications (<3 vs. ≥3), duration of diabetes, and income level were evaluated through stratified analyses and interaction testing with a likelihood ratio test. Statistical analyses were performed using SAS version 9.4 (SAS Institute Inc., Cary, NC, USA), and a P value <0.05 was considered to indicate significance.
Baseline characteristics of the study participants
The characteristics of the participants by household size are described in Table 1. Subjects in the IDLA group were younger, and the proportion of individuals with low income was significantly higher (44.7% in the IDLA group, 18.4% in the non-IDLA group). From a lifestyle perspective, those who consumed alcohol or were current smokers were more frequent, and those who exercised regularly were less frequent in the IDLA group. The prevalence of hypertension, dyslipidemia, and CKD was lower in the IDLA group. Fasting glucose and lipid levels were higher in the IDLA group. Blood pressure, eGFR, and BMI were numerically similar between the groups, but statistically significant differences were observed due to the large sample size. The comparison of participant characteristics by the duration of living alone is described in Supplementary Table 1. The proportions of individuals with unhealthy lifestyle factors and low income were higher among those who had lived alone for a longer period.
The risk of ESKD in individuals with diabetes living alone
During a median follow-up of 6.0 years (IQR, 5.3 to 6.3) after the initial index date, 23,707 participants in the non-IDLA group and 2,984 participants in the IDLA group developed ESKD. The cumulative incidence was higher in the IDLA group (Fig. 1). After adjusting for age and sex, a 21% higher risk of ESKD was observed in the IDLA group (Table 2). After further controlling for other adjusting factors such as income status, smoking, alcohol drinking, regular exercise, BMI, hypertension, dyslipidemia, eGFR, duration of diabetes, and medications, living alone was still an independent predictor of ESKD development (HR, 1.10; 95% CI, 1.06 to 1.14). The incidence and risk of ESKD increased with the duration of living alone, particularly for those who lived alone for more than 5 years (HR, 1.11; 95% CI, 1.07 to 1.16) (Supplementary Table 2). The risk of ESKD was closely related to the level of income in both the IDLA and non-IDLA groups. The risk was increased by 44% in those in the IDLA group who received Medical Aid, compared with people in the highest income quartile who were not living alone. The ESKD risk was also significantly higher in people living alone who were in the lower first or second quartile of household income, but no significant differences were noted in those in the third or fourth quartile of household income (Table 3).
Subgroup analyses
Higher adjusted HRs of incident ESKD were observed in younger individuals (HR, 1.16; 95% CI, 1.11 to 1.22) compared with the older group (HR, 1.03; 95% CI, 0.96 to 1.09). The risk of ESKD in IDLA was more significant in those who consumed alcohol than in non-drinkers. In the non-obese subgroup, IDLA demonstrated a higher risk of ESKD compared to those not living alone (HR, 1.17; 95% CI, 1.11 to 1.24) whereas no significant difference was noted in obese subgroup. In the subgroup analysis by eGFR levels, the risk of ESKD was particularly elevated in the IDLA group with preserved kidney function compared to their non-IDLA counterparts (HR, 1.30; 95% CI, 1.18 to 1.43 in stage 1 CKD; and HR, 1.22; 95% CI, 1.13 to 1.32 in stage 2 CKD). However, for individuals with lower eGFR levels (stage 3–5 CKD), the association between living alone and ESKD risk was not statistically significant (Table 4).
Effect of healthy lifestyle on the risk of ESKD in individuals with diabetes living alone
Adherence to at least one favorable lifestyle habit (non-smoking, abstaining from alcohol, or engaging in regular exercise) reduced the risk of ESKD in both the IDLA and non-IDLA groups (Fig. 2). In the non-IDLA group, there was a 16%, 32%, and 43% risk reduction for ESKD when having one, two, and three healthy lifestyle behaviors, respectively. In the IDLA group, there was a 28%, 46%, and 49% risk reduction for ESKD when having one, two, and three healthy lifestyle behaviors, respectively. The relationship between favorable lifestyle habits and the risk of ESKD was thus more profound in the IDLA group (P for interaction=0.002).
In this nationwide population-based cohort study involving nearly 2.5 million participants, we demonstrated that the IDLA group was associated with a higher risk of developing ESKD than the non-IDLA group. After controlling for possible adjusting factors, the ESKD risk was 10% higher in single-person households. The risk of ESKD varied with the duration of living alone and was particularly high in those who had lived alone for more than 5 years. Subgroup analyses revealed higher risks for younger individuals, alcohol drinkers, non-obese subjects, those without underlying CKD, and those with low income. Adherence to favorable lifestyle habits (non-smoking, abstaining from alcohol, and regular exercise) significantly reduced the ESKD risk in both the IDLA and non-IDLA groups, but the effect was more profound in those living alone.
Several studies have investigated the health outcomes associated with living alone. A meta-analysis demonstrated a higher risk of mortality in the general population living alone, and this association was stronger in younger people and in men [7]. Additionally, social isolation has been linked to multiple chronic diseases in older Europeans [24]. Living alone was significantly associated with an increased risk of hypertension in older Chinese men, which is a risk factor for kidney injury [25]. The incidence of T2DM has also been shown to be higher among Koreans and Germans living alone [8,26]. Middle-aged individuals living alone were at a higher risk for mortality and cardiovascular events, which are typical macrovascular complications. The increase in cardiovascular risk among a patient group considered to be at low risk implies that other factors, such as social determinants of health, are involved [6]. However, no previous research explored the relationship between living alone and the risk of developing microvascular complications such as nephropathy, retinopathy, and neuropathy in people with T2DM. Understanding the effects of living alone on these microvascular complications is crucial because they are significant contributors to the overall morbidity and mortality associated with diabetes.
Several plausible mechanisms could explain the association between the risk of ESKD and living alone. We demonstrated a significant association between adherence to favorable lifestyle factors and a decreased risk of ESKD. Notably, as the number of favorable lifestyle habits increased, the risk of ESKD decreased more substantially. In previous studies, it has been estimated that approximately 90% of T2DM cases and 65% of hypertension cases, the two major causes of CKD, could be prevented if people adhered to a healthy lifestyle including non-smoking, abstaining drinking and regular exercise [27,28]. Regular physical activity has been shown to attenuate declines in renal function in both CKD and acute kidney injury patients [29,30]. Smoking has been associated with the prevalence, development, and progression of kidney disease. Additionally, smoking was significantly associated with renal impairment and proteinuria in a healthy population [31]. Our study showed that higher proportions of people in the IDLA group had unhealthy lifestyle patterns, which might make them vulnerable to comorbidities and increase their risk of ESKD, despite their younger age and lower prevalence of CKD. These results are consistent with previous studies indicating a higher prevalence of CKD in young-onset diabetes [32].
The social determinants of health, including social networks, healthcare accessibility, and economic status, are significant issues for individuals living alone. Existing studies have revealed that participation in community organizations is consistently related to better health status, suggesting that social support plays a crucial role in managing diabetes [33,34]. People living alone tend to use healthcare services less frequently than those living with others and exhibit higher levels of depressive symptoms [35]. People living alone saw a doctor less often and were less likely to have a basic health examination than those living with others, even when controlling for their differences in general and mental health. Notably, the IDLA group had a lower prevalence of hypertension, dyslipidemia, and CKD in our study, likely due to their younger age. Considering these baseline characteristics of the IDLA group, it is conceivable that not only physical health, but also socioeconomic factors had a significant effect. The finding of our subgroup analysis which showed higher risk of ESKD in IDLA without obesity and CKD also emphasizes the importance of social determinants of health influencing critical health outcomes. Additionally, we explored the correlation between income and ESKD incidence in this study and found that a lower income was associated with greater risk. Specifically, higher-income individuals within the IDLA group did not exhibit a significant increase in ESKD risk, whereas lower-income individuals showed a markedly elevated risk. This suggests that financial resources may play a protective role against ESKD progression by enhancing access to healthcare, adherence to treatment, and lifestyle management. Institutional measures and systematic approaches are needed to address these issues effectively, particularly by supporting low-erincome IDLA individuals to reduce this health disparity.
Diabetic kidney disease is a heterogeneous disease and has numerous etiologic pathways. The poor lifestyles and lack of social support found in the IDLA group can lead to difficulties in maintaining metabolic homeostasis. Optimizing glucose control plays a pivotal role in slowing the progression of diabetic kidney disease, with evidence suggesting that intensive glucose control can slow eGFR [36]. Persistent hyperglycemia stimulates the production of advanced glycation end-products, which induces the production of pro-inflammatory cytokines via the activation of nuclear transcription factors [37]. In a Japanese study, living alone was associated with higher glycosylated hemoglobin (HbA1c) and visit-to-visit HbA1c variability in people with diabetes [38]. Social engagement and loneliness are also associated with neuroimmune markers. In the English Longitudinal Study of Ageing, higher levels of social engagement and living with somebody were related to lower levels of C-reactive protein (CRP), fibrinogen, and white blood cell count [39]. In the Copenhagen Aging and Midlife Biobank cohort, a strong association between the duration of living alone or accumulated number of partnership breakups and low-grade inflammation was suggested in middle-aged men [40]. Conversely, a significant reduction in CRP levels was observed after patients with T2DM participated in resistance exercise. Other pro-inflammatory cytokines, including tumor necrosis factor-α and interleukin 6, were also reduced [41]. Therefore, living alone and unhealthy lifestyle conditions can trigger inflammatory responses in the body, leading to disrupted metabolic homeostasis in IDLA.
Our study has several limitations. First, this was an observational study, and the association found between single-person households and renal endpoints might not be causal. Those diagnosed with ESKD within 1 year from the index date were excluded to minimize the possible effects of reverse causality. Second, the precise causes of ESKD were not identifiable in our study. Third, CKD stages are ideally categorized by both eGFR and albuminuria. However, our database lacked information on albuminuria, which may affect the precision of CKD staging in our analysis. Fourth, the study population consisted of Korean men and women; therefore, it is uncertain whether these findings can be generalized to other ethnic groups with different cultural backgrounds and healthcare systems. Fifth, the dietary patterns of the participants were not available. Sixth, indices that reflect the control status of T2DM, such as HbA1c or glycated albumin levels, were not included in this database. We sought to address this limitation by incorporating variables that reflect diabetes severity, such as diabetes duration, insulin usage, and the number of oral antidiabetic medications. Finally, some social determinants that could be confounders were not available in this database, such as marital status, reason of living alone, loneliness, employment status, and severity of comorbidities. Despite those limitations, our study has significant strengths. We analyzed a large number of participants, which is only possible in a large-scale nationwide study. Our study extended the scope of research to include health outcomes across all age groups. Additionally, our study’s detailed, stratified analyses provide insights into how various factors, such as age, income, and lifestyle habits, interact with household status to influence ESKD incidence.
In conclusion, this study has comprehensively explored the multifaceted associations among lifestyle factors, socioeconomic status, and the progression to ESKD within the context of varying living arrangements. Individuals living alone exhibited a unique pattern of associations between risk factors and the development of renal complications. Adherence to favorable lifestyle habits could reduce this risk, emphasizing the need for targeted interventions to improve lifestyle and social support for those living alone. Our study suggests the importance of considering social determinants of health when managing diabetes and preventing its complications. We also provide valuable insights into the complex interplay of lifestyle choices, social factors, and health outcomes and call for institutional measures and systematic approaches to address these issues effectively. Policies that support targeted lifestyle interventions, healthcare accessibility, and social support integration for single-person households with diabetes could be crucial in reducing the progression of diabetic complications in this vulnerable group.
Supplementary materials related to this article can be found online at https://doi.org/10.4093/dmj.2024.0578.
Supplementary Table 1.
Baseline characteristics of study subjects according to their duration of living alone
dmj-2024-0578-Supplementary-Table-1.pdf
Supplementary Table 2.
Risk of end-stage kidney disease according to the duration of living alone
dmj-2024-0578-Supplementary-Table-2.pdf
Supplementary Fig. 1.
Flow chart of the study population. ESKD, end-stage kidney disease.
dmj-2024-0578-Supplementary-Fig-1.pdf

CONFLICTS OF INTEREST

Seung-Hwan Lee has been a managing editor of the Diabetes & Metabolism Journal since 2024. Yong-Moon Mark Park has been a statistical advisor of the Diabetes & Metabolism Journal since 2011. They were not involved in the review process of this article. Otherwise, there was no conflict of interest.

AUTHOR CONTRIBUTIONS

Conception or design: J.S.Y., K.H., S.H.L.

Acquisition, analysis, or interpretation of data: B.K., K.H., S.H.L.

Drafting the work or revising: K.S., H.S.K., J.H.C., Y.M.M.P., S.H.L.

Final approval of the manuscript: all authors.

FUNDING

This research was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (Grant Number: 2022R1F1A1072279) and in part by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UL1 TR003107. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

ACKNOWLEDGMENTS

This work was performed by the cooperation with National Health Insurance Service (NHIS), and the National Health Information Database (NHID) made by NHIS was used. This study was performed as a Korean Diabetes Association–NHIS MOU project.

Fig. 1.
Kaplan-Meier estimates of the cumulative incidence of end-stage kidney disease by living status. IDLA, individuals with diabetes living alone.
dmj-2024-0578f1.jpg
Fig. 2.
Association between healthy lifestyle scores and the risk of end-stage kidney disease by living status. Adjusted for age, sex, smoking, drinking, regular exercise, income, body mass index, hypertension, dyslipidemia, estimated glomerular filtration rate, duration of diabetes, insulin treatment, and oral antidiabetic medications. HR, hazard ratio; CI, confidence interval; IDLA, individuals with diabetes living alone.
dmj-2024-0578f2.jpg
dmj-2024-0578f3.jpg
Table 1.
Baseline characteristics of study subjects according to their living status
Characteristic Total IDLA (–) IDLA (+)
Number 2,432,613 2,177,477 255,136
Age, yr 59.7±12.0 60.0±12.0 57.1±11.9
Male sex 1,477,117 (60.7) 1,320,781 (60.7) 156,336 (61.3)
Smoking
 Non 1,332,065 (54.7) 1,201,581 (55.2) 130,484 (51.1)
 Ex 551,677 (22.7) 502,419 (23.1) 49,258 (19.3)
 Current 548,871 (22.6) 473,477 (21.7) 75,394 (29.6)
Drinking
 Non 1,399,724 (57.5) 1,258,215 (57.8) 141,509 (55.5)
 Mild 810,413 (33.3) 722,655 (33.2) 87,758 (34.4)
 Heavy 222,476 (9.2) 196,607 (9.0) 25,869 (10.1)
Regular exercise 529,781 (21.8) 479,126 (22.0) 50,655 (19.9)
Low income 514,787 (21.2) 400,881 (18.4) 113,906 (44.7)
Hypertension 1,412,106 (58.1) 1,269,592 (58.3) 142,514 (55.9)
Dyslipidemia 1,391,280 (57.2) 1,249,187 (57.4) 142,093 (55.7)
CKD 194,858 (8.0) 177,372 (8.2) 17,486 (6.9)
Height, cm 162.8±9.4 162.8±9.4 163.1±9.2
Weight, kg 67.5±12.6 67.4±12.5 67.8±13.1
BMI, kg/m2 25.3±3.5 25.3±3.5 25.4±3.8
Waist circumference, cm 86.2±9.0 86.2±8.9 86.1±9.5
Systolic BP, mm Hg 128.5±15.0 128.5±15.0 128.1±15.3
Diastolic BP, mm Hg 78.1±9.9 78.0±9.9 78.5±10.2
Fasting glucose, mg/dL 144.5±45.6 144.1±45.0 147.9±49.8
Total cholesterol, mg/dL 185.1±43.6 184.8±43.5 188.3±44.8
HDL-cholesterol, mg/dL 50.9±14.7 50.9±14.6 51.2±15.4
LDL-cholesterol, mg/dL 103.0±38.4 102.9±38.3 104.5±39.2
Triglyceride, mg/dL 134 (93–197) 134 (93–196) 140 (96–208)
eGFR, mL/min/1.73 m2 88.2±19.1 88.0±19.1 90.1±19.3
Insulin treatment 237,716 (9.8) 212,400 (9.8) 25,316 (9.9)
Oral antidiabetic medication ≥3 656,275 (27.0) 589,113 (27.1) 67,162 (26.3)
Duration of diabetes, yr 5.3±5.1 5.4±5.1 4.7±4.9

Values are presented as mean±standard deviation, number (%), or median (interquartile range). P values for the trend were <0.01 for all variables.

IDLA, individuals with diabetes living alone; CKD, chronic kidney disease; BMI, body mass index; BP, blood pressure; HDL, high-density lipoprotein; LDL, low-density lipoprotein; eGFR, estimated glomerular filtration rate.

Table 2.
Risk of end-stage kidney disease according to living status
Variable Number No. of events IR, /1,000 PY HR (95% CI)
Model 1 Model 2 Model 3 Model 4
IDLA (–) 2,177,477 23,707 1.90 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref)
IDLA (+) 255,136 2,984 2.04 1.08 (1.04–1.11) 1.21 (1.17–1.26) 1.07 (1.03–1.11) 1.10 (1.06–1.14)

Model 1: unadjusted; Model 2: adjusted for age and sex; Model 3: adjusted for model 2+smoking, drinking, regular exercise, income, body mass index, hypertension, dyslipidemia, and estimated glomerular filtration rate; Model 4: adjusted for model 3+duration of diabetes, insulin treatment, and oral antidiabetic medications.

IR, incidence rate; PY, person-year; HR, hazard ratio; CI, confidence interval; IDLA, individuals with diabetes living alone.

Table 3.
Risk of end-stage kidney disease according to household income and living status
Income IDLA Number No. of event Incidence rate, /1,000 PY HR (95% CI)
Risk trends Effect modification
Medical aid No 28,360 588 3.70 1.50 (1.38–1.64) 1 (Ref)
Yes 24,662 561 4.13 1.44 (1.32–1.57) 0.96 (0.85–1.08)
Q1 No 372,521 4,215 1.96 1.10 (1.06–1.14) 1 (Ref)
Yes 89,244 1,110 2.18 1.22 (1.15–1.30) 1.11 (1.04–1.19)
Q2 No 398,511 4,295 1.87 1.12 (1.08–1.17) 1 (Ref)
Yes 63,471 662 1.81 1.22 (1.13–1.32) 1.09 (1.00–1.18)
Q3 No 559,452 5,874 1.83 1.05 (1.02–1.09) 1 (Ref)
Yes 47,911 394 1.42 1.09 (0.98–1.21) 1.04 (0.94–1.15)
Q4 No 818,633 8,735 1.86 1 (Ref) 1 (Ref)
Yes 29,848 257 1.49 0.99 (0.88–1.12) 0.99 (0.88–1.12)

Adjusted for age, sex, smoking, drinking, regular exercise, income, body mass index, hypertension, dyslipidemia, estimated glomerular filtration rate, duration of diabetes, insulin treatment, and oral antidiabetic medications.

IDLA, individuals with diabetes living alone; PY, person-year; HR, hazard ratio; CI, confidence interval; Q, quartile.

Table 4.
Stratified analyses of the risk of end-stage kidney according to living status
Subgroup IDLA Number No. of event IR, /1,000 PY HR (95% CI) P for interaction
Male No 1,320,781 15,763 2.09 1 (Ref) 0.324
Yes 156,336 2,073 2.33 1.12 (1.07–1.17)
Female No 856,696 7,944 1.60 1 (Ref)
Yes 98,800 911 1.59 1.07 (1.00–1.15)
Age <65 yr No 1,397,390 10,761 1.32 1 (Ref) 0.002
Yes 190,240 1,932 1.76 1.16 (1.11–1.22)
Age ≥65 yr No 780,087 12,946 2.99 1 (Ref)
Yes 64,896 1,052 2.90 1.03 (0.96–1.09)
Current smoking (–) No 1,704,000 18,946 1.93 1 (Ref) 0.307
Yes 179,742 2,052 1.98 1.09 (1.04–1.14)
Current smoking (+) No 473,477 4,761 1.76 1 (Ref)
Yes 75,394 932 2.18 1.14 (1.06–1.22)
Alcohol consumption (–) No 1,258,215 16,916 2.36 1 (Ref) <0.001
Yes 141,509 2,011 2.49 1.05 (1.00–1.10)
Alcohol consumption (+) No 919,262 6,791 1.27 1 (Ref)
Yes 113,627 973 1.49 1.22 (1.14–1.31)
Regular exercise (–) No 1,698,351 19,174 1.97 1 (Ref) 0.839
Yes 204,481 2,446 2.09 1.11 (1.06–1.15)
Regular exercise (+) No 479,126 4,533 1.63 1 (Ref)
Yes 50,655 538 1.84 1.09 (1–1.20)
Obesity (–) No 1,064,991 12,510 2.06 1 (Ref) 0.001
Yes 123,931 1,642 2.33 1.17 (1.11–1.24)
Obesity (+) No 1,112,486 11,197 1.74 1 (Ref)
Yes 131,205 1,342 1.77 1.03 (0.97–1.09)
CKD stage 1 (eGFR ≥90 mL/min/1.73 m2) No 1,105,432 2,903 0.45 1 (Ref) <0.001
Yes 139,349 474 0.59 1.30 (1.18–1.43)
CKD stage 2 (60≤ eGFR <90 mL/min/1.73 m2) No 894,673 5,617 1.09 1 (Ref)
Yes 98,301 795 1.41 1.22 (1.13–1.32)
CKD stage 3 (30≤ eGFR <60 mL/min/1.73 m2) No 167,261 10,377 11.7 1 (Ref)
Yes 16,449 1,189 13.6 1.06 (0.99–1.12)
CKD stage 4–5 (eGFR <30 mL/min/1.73 m2) No 10,111 4,810 139.3 1 (Ref)
Yes 1,037 526 149.8 0.94 (0.86–1.03)
Insulin treatment (–) No 1,965,077 13,981 1.23 1 (Ref) 0.134
Yes 229,820 1,772 1.34 1.13 (1.07–1.19)
Insulin treatment (+) No 212,400 9,726 8.56 1 (Ref)
Yes 25,316 1,212 8.95 1.07 (1.00–1.13)
OAM ≤2 No 1,588,364 14,543 1.59 1 (Ref) 0.187
Yes 187,974 1,795 1.66 1.08 (1.03–1.14)
OAM ≥3 No 589,113 9,164 2.73 1 (Ref)
Yes 67,162 1,189 3.11 1.14 (1.07–1.21)
DM duration <5 yr No 1,162,352 3,927 0.58 1 (Ref) 0.262
Yes 149,400 602 0.70 1.13 (1.04–1.24)
DM duration 5–10 yr No 455,896 4,225 1.61 1 (Ref)
Yes 53,042 702 2.30 1.15 (1.06–1.25)
DM duration ≥10 yr No 559,229 15,555 4.97 1 (Ref)
Yes 52,694 1,680 5.71 1.07 (1.02–1.13)

Adjusted for age, sex, smoking, drinking, regular exercise, income, body mass index, hypertension, dyslipidemia, estimated glomerular filtration rate, duration of diabetes, insulin treatment, and oral antidiabetic medications.

IDLA, individuals with diabetes living alone; IR, incidence rate; PY, person-year; HR, hazard ratio; CI, confidence interval; CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate; OAM, oral antidiabetic medication; DM, diabetes mellitus.

  • 1. United States Census Bureau. One-person households on the rise. Available from: https://www.census.gov/library/visualizations/2019/comm/one-person-households.html (cited 2025 Mar 10.
  • 2. Statistics Korea. 2021 Population and housing census (register-based census). Available from: https://kostat.go.kr/board.es?mid=a20108070000&bid=11747&tag=&act=view&list_no=419981&ref_bid= (cited 2025 Mar 22).
  • 3. Hanna KL, Collins PF. Relationship between living alone and food and nutrient intake. Nutr Rev 2015;73:594-611.ArticlePubMed
  • 4. Lim HS, Lee MN. Comparison of health status and nutrient intake by household type in the elderly population. J Bone Metab 2019;26:25-30.ArticlePubMedPMCPDF
  • 5. Zhu Z, Peng Z, Xing Z. Living alone is not associated with cardiovascular events and hypoglycemia in patients with type 2 diabetes mellitus. Front Public Health 2022;10:883383.ArticlePubMedPMC
  • 6. Udell JA, Steg PG, Scirica BM, Smith SC Jr, Ohman EM, Eagle KA, et al. Living alone and cardiovascular risk in outpatients at risk of or with atherothrombosis. Arch Intern Med 2012;172:1086-95.ArticlePubMed
  • 7. Zhao Y, Guyatt G, Gao Y, Hao Q, Abdullah R, Basmaji J, et al. Living alone and all-cause mortality in community-dwelling adults: a systematic review and meta-analysis. EClinicalMedicine 2022;54:101677.ArticlePubMed
  • 8. Meisinger C, Kandler U, Ladwig KH. Living alone is associated with an increased risk of type 2 diabetes mellitus in men but not women from the general population: the MONICA/KORA Augsburg Cohort Study. Psychosom Med 2009;71:784-8.ArticlePubMed
  • 9. Kim NH, Seo MH, Jung JH, Han KD, Kim MK, Kim NH. 2023 Diabetic kidney disease fact sheet in Korea. Diabetes Metab J 2024;48:463-72.ArticlePDF
  • 10. Nothlings U, Ford ES, Kroger J, Boeing H. Lifestyle factors and mortality among adults with diabetes: findings from the European Prospective Investigation into Cancer and NutritionPotsdam study. J Diabetes 2010;2:112-7.ArticlePubMed
  • 11. BeLue R, Diaw M, Ndao F, Okoror T, Degboe A, Abiero B. A cultural lens to understanding daily experiences with type 2 diabetes self-management among clinic patients in M’bour, Senegal. Int Q Community Health Educ 2012;33:329-47.ArticlePubMedPDF
  • 12. Jalilian H, Javanshir E, Torkzadeh L, Fehresti S, Mir N, Heidari-Jamebozorgi M, et al. Prevalence of type 2 diabetes complications and its association with diet knowledge and skills and self-care barriers in Tabriz, Iran: a cross-sectional study. Health Sci Rep 2023;6:e1096.ArticlePubMedPMCPDF
  • 13. Jin DC, Yun SR, Lee SW, Han SW, Kim W, Park J, et al. Lessons from 30 years’ data of Korean end-stage renal disease registry, 1985-2015. Kidney Res Clin Pract 2015;34:132-9.Article
  • 14. Dunkler D, Kohl M, Heinze G, Teo KK, Rosengren A, Pogue J, et al. Modifiable lifestyle and social factors affect chronic kidney disease in high-risk individuals with type 2 diabetes mellitus. Kidney Int 2015;87:784-91.ArticlePubMed
  • 15. Kim MK, Han K, Lee SH. Current trends of big data research using the Korean national health information database. Diabetes Metab J 2022;46:552-63.ArticlePubMedPMCPDF
  • 16. Cho SW, Kim JH, Choi HS, Ahn HY, Kim MK, Rhee EJ. Big data research in the field of endocrine diseases using the Korean national health information database. Endocrinol Metab (Seoul) 2023;38:10-24.ArticlePubMedPMCPDF
  • 17. Yoo JE, Shin DW, Han K, Kim D, Jeong SM, Koo HY, et al. Association of the frequency and quantity of alcohol consumption with gastrointestinal cancer. JAMA Netw Open 2021;4:e2120382.ArticlePubMedPMC
  • 18. Cheon DY, Han KD, Lee YJ, Lee JH, Park MS, Kim DY, et al. Association between physical activity changes and incident myocardial infarction after ischemic stroke: a nationwide population-based study. BMC Public Health 2024;24:1241.ArticlePubMedPMCPDF
  • 19. Lee SR, Choi EK, Park SH, Lee SW, Han KD, Oh S, et al. Clustering of unhealthy lifestyle and the risk of adverse events in patients with atrial fibrillation. Front Cardiovasc Med 2022;9:885016.ArticlePubMedPMC
  • 20. Baek JH, Park YM, Han KD, Moon MK, Choi JH, Ko SH. Comparison of operational definition of type 2 diabetes mellitus based on data from Korean National Health Insurance Service and Korea National Health and Nutrition Examination Survey. Diabetes Metab J 2023;47:201-10.ArticlePMCPDF
  • 21. Haam JH, Kim BT, Kim EM, Kwon H, Kang JH, Park JH, et al. Diagnosis of obesity: 2022 update of clinical practice guidelines for obesity by the Korean Society for the Study of Obesity. J Obes Metab Syndr 2023;32:121-9.ArticlePubMedPMC
  • 22. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006;145:247-54.ArticlePubMed
  • 23. Kim MK, Han K, Koh ES, Kim HS, Kwon HS, Park YM, et al. Variability in total cholesterol is associated with the risk of endstage renal disease: a nationwide population-based study. Arterioscler Thromb Vasc Biol 2017;37:1963-70.
  • 24. Cantarero-Prieto D, Pascual-Saez M, Blazquez-Fernandez C. Social isolation and multiple chronic diseases after age 50: a European macro-regional analysis. PLoS One 2018;13:e0205062.ArticlePubMedPMC
  • 25. Wang X, Dai M, Xu J. Association of living alone and living alone time with hypertension among Chinese men aged 80years and older: a cohort study. Front Public Health 2024;11:1274955.ArticlePubMed
  • 26. Nam GE, Kim W, Han K, Jung JH, Han B, Kim J, et al. Association between living alone and incident type 2 diabetes among middle-aged individuals in Korea: a nationwide cohort study. Sci Rep 2021;11:3659.ArticlePubMedPMCPDF
  • 27. Garrison RJ, Kannel WB, Stokes J 3rd, Castelli WP. Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. Prev Med 1987;16:235-51.Article
  • 28. Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG, et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 2001;345:790-7.ArticlePubMed
  • 29. Asad A, Thomas A, Dungey M, Hull KL, March DS, Burton JO. Associations between physical activity levels and renal recovery following acute kidney injury stage 3: a feasibility study. BMC Nephrol 2022;23:140.ArticlePubMedPMCPDF
  • 30. Rampersad C, Brar R, Connelly K, Komenda P, Rigatto C, Prasad B, et al. Association of physical activity and poor health outcomes in patients with advanced CKD. Am J Kidney Dis 2021;78:391-8.Article
  • 31. Briganti EM, Branley P, Chadban SJ, Shaw JE, McNeil JJ, Welborn TA, et al. Smoking is associated with renal impairment and proteinuria in the normal population: the AusDiab kidney study. Australian Diabetes, Obesity and Lifestyle Study. Am J Kidney Dis 2002;40:704-12.
  • 32. Lee J, Lee SH, Yoon KH, Cho JH, Han K, Yang Y. Risk of developing chronic kidney disease in young-onset type 2 diabetes in Korea. Sci Rep 2023;13:10100.ArticlePMCPDF
  • 33. Koetsenruijter J, van Lieshout J, Lionis C, Portillo MC, Vassilev I, Todorova E, et al. Social support and health in diabetes patients: an observational study in six European countries in an era of austerity. PLoS One 2015;10:e0135079.ArticlePubMedPMC
  • 34. Maxwell AE, Hunt IF, Bush MA. Effects of a social support group, as an adjunct to diabetes training, on metabolic control and psychosocial outcomes. Diabetes Educ 1992;18:303-9.ArticlePDF
  • 35. Solin PC, Pasanen TP, Mankinen KA, Martelin TP, Tamminen NM. Use of health services among people living alone in Finland. Health Serv Insights 2021;14:11786329211043955.ArticlePubMedPDF
  • 36. MacIsaac RJ, Jerums G, Ekinci EI. Effects of glycaemic management on diabetic kidney disease. World J Diabetes 2017;8:172-86.ArticlePubMed
  • 37. Bierhaus A, Humpert PM, Morcos M, Wendt T, Chavakis T, Arnold B, et al. Understanding RAGE, the receptor for advanced glycation end products. J Mol Med (Berl) 2005;83:876-86.ArticlePubMedPDF
  • 38. Sakai R, Hashimoto Y, Hamaguchi M, Ushigome E, Okamura T, Majima S, et al. Living alone is associated with visit-to-visit HbA1c variability in men but not in women in people with type 2 diabetes: KAMOGAWA-DM cohort study. Endocr J 2020;67:419-26.ArticlePubMed
  • 39. Walker E, Ploubidis G, Fancourt D. Social engagement and loneliness are differentially associated with neuro-immune markers in older age: time-varying associations from the English Longitudinal Study of Ageing. Brain Behav Immun 2019;82:224-9.ArticlePubMedPMC
  • 40. Davidsen K, Carstensen S, Kriegbaum M, Bruunsgaard H, Lund R. Do partnership dissolutions and living alone affect systemic chronic inflammation?: a cohort study of Danish adults. J Epidemiol Community Health 2022;76:490-6.Article
  • 41. Fernandez-Rodriguez R, Monedero-Carrasco S, Bizzozero-Peroni B, Garrido-Miguel M, Mesas AE, Martinez-Vizcaino V. Effectiveness of resistance exercise on inflammatory biomarkers in patients with type 2 diabetes mellitus: a systematic review with meta-analysis. Diabetes Metab J 2023;47:118-34.ArticlePubMedPDF

Figure & Data

References

    Citations

    Citations to this article as recorded by  

      • PubReader PubReader
      • ePub LinkePub Link
      • Cite this Article
        Cite this Article
        export Copy Download
        Close
        Download Citation
        Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

        Format:
        • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
        • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
        Include:
        • Citation for the content below
        Risk of End-Stage Kidney Disease in Individuals with Diabetes Living Alone: A Large-Scale Population-Based Study
        Close
      • XML DownloadXML Download
      Figure
      • 0
      • 1
      • 2
      Related articles
      Risk of End-Stage Kidney Disease in Individuals with Diabetes Living Alone: A Large-Scale Population-Based Study
      Image Image Image
      Fig. 1. Kaplan-Meier estimates of the cumulative incidence of end-stage kidney disease by living status. IDLA, individuals with diabetes living alone.
      Fig. 2. Association between healthy lifestyle scores and the risk of end-stage kidney disease by living status. Adjusted for age, sex, smoking, drinking, regular exercise, income, body mass index, hypertension, dyslipidemia, estimated glomerular filtration rate, duration of diabetes, insulin treatment, and oral antidiabetic medications. HR, hazard ratio; CI, confidence interval; IDLA, individuals with diabetes living alone.
      Graphical abstract
      Risk of End-Stage Kidney Disease in Individuals with Diabetes Living Alone: A Large-Scale Population-Based Study
      Characteristic Total IDLA (–) IDLA (+)
      Number 2,432,613 2,177,477 255,136
      Age, yr 59.7±12.0 60.0±12.0 57.1±11.9
      Male sex 1,477,117 (60.7) 1,320,781 (60.7) 156,336 (61.3)
      Smoking
       Non 1,332,065 (54.7) 1,201,581 (55.2) 130,484 (51.1)
       Ex 551,677 (22.7) 502,419 (23.1) 49,258 (19.3)
       Current 548,871 (22.6) 473,477 (21.7) 75,394 (29.6)
      Drinking
       Non 1,399,724 (57.5) 1,258,215 (57.8) 141,509 (55.5)
       Mild 810,413 (33.3) 722,655 (33.2) 87,758 (34.4)
       Heavy 222,476 (9.2) 196,607 (9.0) 25,869 (10.1)
      Regular exercise 529,781 (21.8) 479,126 (22.0) 50,655 (19.9)
      Low income 514,787 (21.2) 400,881 (18.4) 113,906 (44.7)
      Hypertension 1,412,106 (58.1) 1,269,592 (58.3) 142,514 (55.9)
      Dyslipidemia 1,391,280 (57.2) 1,249,187 (57.4) 142,093 (55.7)
      CKD 194,858 (8.0) 177,372 (8.2) 17,486 (6.9)
      Height, cm 162.8±9.4 162.8±9.4 163.1±9.2
      Weight, kg 67.5±12.6 67.4±12.5 67.8±13.1
      BMI, kg/m2 25.3±3.5 25.3±3.5 25.4±3.8
      Waist circumference, cm 86.2±9.0 86.2±8.9 86.1±9.5
      Systolic BP, mm Hg 128.5±15.0 128.5±15.0 128.1±15.3
      Diastolic BP, mm Hg 78.1±9.9 78.0±9.9 78.5±10.2
      Fasting glucose, mg/dL 144.5±45.6 144.1±45.0 147.9±49.8
      Total cholesterol, mg/dL 185.1±43.6 184.8±43.5 188.3±44.8
      HDL-cholesterol, mg/dL 50.9±14.7 50.9±14.6 51.2±15.4
      LDL-cholesterol, mg/dL 103.0±38.4 102.9±38.3 104.5±39.2
      Triglyceride, mg/dL 134 (93–197) 134 (93–196) 140 (96–208)
      eGFR, mL/min/1.73 m2 88.2±19.1 88.0±19.1 90.1±19.3
      Insulin treatment 237,716 (9.8) 212,400 (9.8) 25,316 (9.9)
      Oral antidiabetic medication ≥3 656,275 (27.0) 589,113 (27.1) 67,162 (26.3)
      Duration of diabetes, yr 5.3±5.1 5.4±5.1 4.7±4.9
      Variable Number No. of events IR, /1,000 PY HR (95% CI)
      Model 1 Model 2 Model 3 Model 4
      IDLA (–) 2,177,477 23,707 1.90 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref)
      IDLA (+) 255,136 2,984 2.04 1.08 (1.04–1.11) 1.21 (1.17–1.26) 1.07 (1.03–1.11) 1.10 (1.06–1.14)
      Income IDLA Number No. of event Incidence rate, /1,000 PY HR (95% CI)
      Risk trends Effect modification
      Medical aid No 28,360 588 3.70 1.50 (1.38–1.64) 1 (Ref)
      Yes 24,662 561 4.13 1.44 (1.32–1.57) 0.96 (0.85–1.08)
      Q1 No 372,521 4,215 1.96 1.10 (1.06–1.14) 1 (Ref)
      Yes 89,244 1,110 2.18 1.22 (1.15–1.30) 1.11 (1.04–1.19)
      Q2 No 398,511 4,295 1.87 1.12 (1.08–1.17) 1 (Ref)
      Yes 63,471 662 1.81 1.22 (1.13–1.32) 1.09 (1.00–1.18)
      Q3 No 559,452 5,874 1.83 1.05 (1.02–1.09) 1 (Ref)
      Yes 47,911 394 1.42 1.09 (0.98–1.21) 1.04 (0.94–1.15)
      Q4 No 818,633 8,735 1.86 1 (Ref) 1 (Ref)
      Yes 29,848 257 1.49 0.99 (0.88–1.12) 0.99 (0.88–1.12)
      Subgroup IDLA Number No. of event IR, /1,000 PY HR (95% CI) P for interaction
      Male No 1,320,781 15,763 2.09 1 (Ref) 0.324
      Yes 156,336 2,073 2.33 1.12 (1.07–1.17)
      Female No 856,696 7,944 1.60 1 (Ref)
      Yes 98,800 911 1.59 1.07 (1.00–1.15)
      Age <65 yr No 1,397,390 10,761 1.32 1 (Ref) 0.002
      Yes 190,240 1,932 1.76 1.16 (1.11–1.22)
      Age ≥65 yr No 780,087 12,946 2.99 1 (Ref)
      Yes 64,896 1,052 2.90 1.03 (0.96–1.09)
      Current smoking (–) No 1,704,000 18,946 1.93 1 (Ref) 0.307
      Yes 179,742 2,052 1.98 1.09 (1.04–1.14)
      Current smoking (+) No 473,477 4,761 1.76 1 (Ref)
      Yes 75,394 932 2.18 1.14 (1.06–1.22)
      Alcohol consumption (–) No 1,258,215 16,916 2.36 1 (Ref) <0.001
      Yes 141,509 2,011 2.49 1.05 (1.00–1.10)
      Alcohol consumption (+) No 919,262 6,791 1.27 1 (Ref)
      Yes 113,627 973 1.49 1.22 (1.14–1.31)
      Regular exercise (–) No 1,698,351 19,174 1.97 1 (Ref) 0.839
      Yes 204,481 2,446 2.09 1.11 (1.06–1.15)
      Regular exercise (+) No 479,126 4,533 1.63 1 (Ref)
      Yes 50,655 538 1.84 1.09 (1–1.20)
      Obesity (–) No 1,064,991 12,510 2.06 1 (Ref) 0.001
      Yes 123,931 1,642 2.33 1.17 (1.11–1.24)
      Obesity (+) No 1,112,486 11,197 1.74 1 (Ref)
      Yes 131,205 1,342 1.77 1.03 (0.97–1.09)
      CKD stage 1 (eGFR ≥90 mL/min/1.73 m2) No 1,105,432 2,903 0.45 1 (Ref) <0.001
      Yes 139,349 474 0.59 1.30 (1.18–1.43)
      CKD stage 2 (60≤ eGFR <90 mL/min/1.73 m2) No 894,673 5,617 1.09 1 (Ref)
      Yes 98,301 795 1.41 1.22 (1.13–1.32)
      CKD stage 3 (30≤ eGFR <60 mL/min/1.73 m2) No 167,261 10,377 11.7 1 (Ref)
      Yes 16,449 1,189 13.6 1.06 (0.99–1.12)
      CKD stage 4–5 (eGFR <30 mL/min/1.73 m2) No 10,111 4,810 139.3 1 (Ref)
      Yes 1,037 526 149.8 0.94 (0.86–1.03)
      Insulin treatment (–) No 1,965,077 13,981 1.23 1 (Ref) 0.134
      Yes 229,820 1,772 1.34 1.13 (1.07–1.19)
      Insulin treatment (+) No 212,400 9,726 8.56 1 (Ref)
      Yes 25,316 1,212 8.95 1.07 (1.00–1.13)
      OAM ≤2 No 1,588,364 14,543 1.59 1 (Ref) 0.187
      Yes 187,974 1,795 1.66 1.08 (1.03–1.14)
      OAM ≥3 No 589,113 9,164 2.73 1 (Ref)
      Yes 67,162 1,189 3.11 1.14 (1.07–1.21)
      DM duration <5 yr No 1,162,352 3,927 0.58 1 (Ref) 0.262
      Yes 149,400 602 0.70 1.13 (1.04–1.24)
      DM duration 5–10 yr No 455,896 4,225 1.61 1 (Ref)
      Yes 53,042 702 2.30 1.15 (1.06–1.25)
      DM duration ≥10 yr No 559,229 15,555 4.97 1 (Ref)
      Yes 52,694 1,680 5.71 1.07 (1.02–1.13)
      Table 1. Baseline characteristics of study subjects according to their living status

      Values are presented as mean±standard deviation, number (%), or median (interquartile range). P values for the trend were <0.01 for all variables.

      IDLA, individuals with diabetes living alone; CKD, chronic kidney disease; BMI, body mass index; BP, blood pressure; HDL, high-density lipoprotein; LDL, low-density lipoprotein; eGFR, estimated glomerular filtration rate.

      Table 2. Risk of end-stage kidney disease according to living status

      Model 1: unadjusted; Model 2: adjusted for age and sex; Model 3: adjusted for model 2+smoking, drinking, regular exercise, income, body mass index, hypertension, dyslipidemia, and estimated glomerular filtration rate; Model 4: adjusted for model 3+duration of diabetes, insulin treatment, and oral antidiabetic medications.

      IR, incidence rate; PY, person-year; HR, hazard ratio; CI, confidence interval; IDLA, individuals with diabetes living alone.

      Table 3. Risk of end-stage kidney disease according to household income and living status

      Adjusted for age, sex, smoking, drinking, regular exercise, income, body mass index, hypertension, dyslipidemia, estimated glomerular filtration rate, duration of diabetes, insulin treatment, and oral antidiabetic medications.

      IDLA, individuals with diabetes living alone; PY, person-year; HR, hazard ratio; CI, confidence interval; Q, quartile.

      Table 4. Stratified analyses of the risk of end-stage kidney according to living status

      Adjusted for age, sex, smoking, drinking, regular exercise, income, body mass index, hypertension, dyslipidemia, estimated glomerular filtration rate, duration of diabetes, insulin treatment, and oral antidiabetic medications.

      IDLA, individuals with diabetes living alone; IR, incidence rate; PY, person-year; HR, hazard ratio; CI, confidence interval; CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate; OAM, oral antidiabetic medication; DM, diabetes mellitus.

      Sung K, Yun JS, Kim B, Kim HS, Cho JH, Park YMM, Han K, Lee SH. Risk of End-Stage Kidney Disease in Individuals with Diabetes Living Alone: A Large-Scale Population-Based Study. Diabetes Metab J. 2025 Apr 5. doi: 10.4093/dmj.2024.0578. Epub ahead of print.
      Received: Sep 20, 2024; Accepted: Dec 12, 2024
      DOI: https://doi.org/10.4093/dmj.2024.0578.

      Diabetes Metab J : Diabetes & Metabolism Journal
      Close layer
      TOP